| Identification | |
| Name: | 19-Norpregn-5(10)-en-20-yn-3-one,17-hydroxy-7-methyl-, (7a,17a)- |
| Synonyms: | 19-Nor-17a-pregn-5(10)-en-20-yn-3-one, 17-hydroxy-7a-methyl- (7CI,8CI);(7a,17a)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one;7a-Methyl-17a-ethynyl-17b-hydroxy-5(10)-estren-3-one;7a-Methyl-D5,10-norethindrone;Livial;Liviella;Org OD 14; |
| CAS: | 5630-53-5 |
| EINECS: | 227-069-1 |
| Molecular Formula: | C21H28O2 |
| Molecular Weight: | 312.44582 |
| InChI: | InChI=1S/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,17-19,23H,5-12H2,2-3H3/t13-,17-,18+,19-,20+,21+/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | HAZARD |
| Melting Point: | 163 - 169 C |
| Density: | 1.13g/cm3 |
| Water Solubility: | practically insoluble (soluble in chloroform, methanol) |
| Solubility: | practically insoluble (soluble in chloroform, methanol) |
| Appearance: | white to off-white crystalline powder |
| Specification: | White Solid usageEng:A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome Safety Statements:22-24/25-61 22:Do not breathe dust 24/25:Avoid contact with skin and eyes 61:Avoid release to the environment. Refer to special instructions safety data sheet |
| Usage: | A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome |
| Safety Data | |
 |
|
